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Abstract: Bioactive molecules in berries may be helpful in reducing the risk of oral diseases. 
The aim of this study was to determine the effect of bilberry consumption on the outcome of 
a routine dental clinical parameter of inflammation, bleeding on probing (BOP), as well as 
the impact on selected biomarkers of inflammation, such as cytokines, in gingival crevicular 
fluid (GCF) in individuals with gingivitis. Study individuals who did not receive standard of 
care treatment were allocated to either a placebo group or to groups that consumed either 
250 or 500 g bilberries daily over seven days. The placebo group consumed an inactive 
product (starch). A study group, receiving standard of care (debridement only) was also 
included to provide a reference to standard of care treatment outcome. Cytokine levels were 
assayed using the Luminex MagPix system. The mean reduction in BOP before and after 
consumption of test product over 1 week was 41% and 59% in the groups that consumed 
either 250 or 500 g of bilberries/day respectively, and was 31% in the placebo group,  
and 58% in the standard of care reference group. The analysis only showed a significant 
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reduction in cytokine levels in the group that consumed 500 g of bilberries/day. A statistically 
significant reduction was observed for IL-1β (p = 0.025), IL-6 (p = 0.012) and VEGF  
(p = 0.017) in GCF samples in the group that consumed 500 g of bilberries daily. It appears 
that berry intake has an ameliorating effect on some markers of gingival inflammation 
reducing gingivitis to a similar extent compared to standard of care.  
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1. Introduction 
Gingivitis (bleeding from the gums) is a common clinical feature and as many as 50% of teenagers 
in Sweden may have gingivitis [1]. This condition presents as swelling, redness and bleeding at the gums 
and is an inflammatory reaction driven by the release of pro-inflammatory cytokines, although it is 
reversible [2]. Assessment of the frequency of gingival bleeding is the standard method to diagnose 
gingivitis, and is referred to as “bleeding on probing” (BOP). As a result of the local gingival 
inflammatory response, an exudate (gingival crevicular fluid, GCF) from the area between the tooth and 
the gum tissues effectively reflects serum composition, including the presence of cytokines [3], which 
modulate the balance between humoral and cell-based immune responses.  
Good health is associated with adequate fruit and berry intake. There is a growing documentation on 
antioxidant [4–6], anti-inflammatory [7] and antibacterial [8] effects of berries, which is strongly 
associated with the phenolic content. Bilberries (Vaccinium myrtillus) contain compounds that may 
control inflammation [7]. A reduction in gingival inflammation and beneficial changes in the oral 
microbiota have been reported in humans on a restricted diet typical for the “Stone Age” where oral 
hygiene is maintained in the absence of tooth brushing [9]. Indeed, encapsulated fruit, vegetable and 
berry juice concentrates appear to improve gingival conditions [10].  
The scope of the present study was to determine the outcome on oral inflammation, and levels of 
cytokines in GCF after the consumption of 250 or 500 g bilberries daily over seven days in individuals 
with gingivitis. The same biomarkers were also studied in a placebo group.  
2. Results and Discussion 
Data from 24 adult individuals, 17 females (70.8%) and 7 males (29.2%), with gingivitis and  
a mean age of 28 years (S.D. ± 11) were included. Standard of care reference group: 8 adult individuals, 
4 females (50%), 4 males (50%), age 50.5 years (S.D. ± 9.5). Baseline bleeding on probing 39.6%  
(S.D. ± 8.1) and after 6 months 17.1% (S.D ± 7.7). The mean reduction in bleeding on probing before 
and after consumption of test product was 41% in the group that consumed 250 g bilberries/day, 59% in 
individuals who consumed 500 g bilberries/day, and 31% in the placebo group (Table 1). The mean 
reduction in bleeding was 58% in the group that served as standard of care reference group receiving 
debridement and oral hygiene instructions only. Data analysis demonstrated that the change in BOP over 
the study period differed significantly between baseline and study endpoint in all groups. However, there 
was only a statistical change in BOP between the 500 g bilberry and placebo group and the reduction in 
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BOP was unexpectedly high. While this observation might be explained in terms of “the Hawthorne 
effect”, where study individuals devote greater attention to a given task due to the attention being focused 
on them, in this report the individuals stated that they had not consciously changed their oral hygiene. 
The reduction of gingivitis (bleeding) from the berry intake with 500 g bilberry as reported was 
surprising but consistent with a report on the reduction in gingival inflammation, where individuals lived 
on a restricted diet without sugar, but rich in berry intake [9]. The present study also demonstrated that 
participating in a study such as in the present one resulted in improvement of gingival (gum) conditions 
that is greater than the Hawthorne effect. Thus, it is important to include not only a placebo control  
group but also a reference to the results of the “standard of care” treatment. The reduction in the  
extent of bleeding in the reference group reported here is consistent with many other reports and  
clinical experiences. 
Table 1. Baseline and study end point clinical bleeding on probing (BOP) (%) in the bilberry, 
placebo and standard of care reference groups. (BL = baseline, EP = study endpoint,  
Ch = change, SOC = standard of care). 
Individual 250 g Bilberry 500 g Bilberry Placebo SOC 
 
BL 
(%)
EP 
(%) 
Ch 
(%) 
BL 
(%)
EP 
(%)
Ch 
(%)
BL 
(%)
EP 
(%)
Ch 
(%)
BL 
(%) 
EP 
(%) 
Ch 
(%)
1 13 6 54 34 18 47 37 15 59 53 18 66 
2 23 11 52 48 33 31 54 54 0 32 14 56 
3 28 17 39 30 8 73 25 25 0 43 27 37 
4 25 14 44 29 15 48 39 26 33 33 4 88 
5 33 21 36 24 8 67 31 21 32 33 12 64 
6 21 11 48 39 16 59 26 14 46 36 20 44 
7 23 19 17 39 10 74 31 16 48 37 15 59 
8 23 15 35 25 7 72 26 18 31 50 27 46 
mean 25 15 41 34 14 59 34 24 31 40 17 58 
No significant changes in cytokine levels were found in the placebo group or in the berry group that 
consumed 250 g of bilberries. The analysis identified significant differences between baseline and study 
endpoint after intake of 500 g of bilberries/day for three of the cytokines studied: interleukin (IL)-1β  
(p = 0.025), IL-6 (p = 0.012), and vascular endothelial growth factor (VEGF) (p = 0.017) (Figure 1A–C 
and Table 2). 
Berry components may serve as bioactive molecules for the prevention and/or treatment of 
inflammatory diseases, including gingival inflammation. It remains to be established, as to the optimal 
degree of consumption and species of berries that may provide clinically measurable effects on 
inflammation [11]. The guidelines provided by the Swedish National Food Agency suggest a daily intake 
of 500 g fruits, berries and vegetables. We have identified that bilberries may be one of many berries 
that can be consumed on a daily basis at such amounts. Bleeding on probing was effectively reduced 
following intake of 500 g bilberries, whereas an intake of 250 g was not sufficient to reduce gingival 
inflammation. Standard of care resulted i similar changes in bleeding on probing as did the intake of  
500 g bilberries. This average reduction (59%) among individuals consuming 500 g of bilberries is 
clinically relevant. In fact, this reduction exceeds the changes of gingival inflammation presented in 
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many studies of experimental gingivitis and resolution of inflammation through the introduction of 
improved oral hygiene procedures [12–14]. The observed reduction is also remarkable considering the 
fact that none of the study individuals had severe inflammation at baseline. Based on our findings, daily 
intake of bilberries could potentially control gingival inflammation in the general population. It appears 
that there are no studies reporting adverse effects of long-term intake of bilberries at daily dosages used 
in the present study and none of the participants reported adverse effects related to the dietary intake of 
bilberries. Assuming that gingival inflammation is only one expression of inflammation, the positive 
impact on health could be important if bilberry consumption has similar effects on human inflammation 
in other tissues and organs. We also observed changes in serum cytokine levels but failed to identify that 
the intake of bilberries at 500 g level had any significant impact. It is possible that berry intake over 
seven days is not sufficient to induce systemic effects. Whilst the inflammatory changes in the present 
study reflect the impact of bilberry consumption in chronic inflammatory conditions, it is unknown as 
to whether cases of acute inflammation may respond in a similar fashion [7]. 
  
 
Figure 1. Boxplot diagram (median values, 25th and 75th percentiles, open circle represents 
outlier value) illustrating gingival crevicular fluid (GCF) changes in IL-1β (A); IL-6 (B); 
and VEGF (C) between baseline and at study endpoint in individuals who consumed 500 g 
bilberries daily.  
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Table 2. Concentrations of IL-1β, IL-1ra, IL-6, IL-12, MIP-1α, PDGF, and VEGF in 
gingival crevicular fluid in the groups that consumed 250 or 500 g bilberries/day or placebo 
over seven days. Data are presented for median values, 25th and 75th percentile due to  
non-normal distribution. Exact p-values are presented. 
Cytokine 
Median 
pg/mL 
25% 
pg/mL 
75% 
pg/mL 
Median 
pg/mL 
25% 
pg/mL 
75% 
pg/mL 
Median 
Ratio 
p Value 
 250 g bilberry baseline 250 g bilberry study end point   
IL-1ra 0.7 0.2 6.9 0.4 0.0 35.8 1.8 0.715 
IL-1β 18.0 10.7 144.2 29.6 6.2 146.0 0.6 0.715 
IL-6 84.8 52.9 96.0 67.7 34.3 106.5 1.3 0.715 
IL-12 0.8 0.8 1.4 0.8 0.6 1.4 1.0 0.317 
IP-10 371.5 235.9 689.0 522.5 196.7 1392.2 0.7 0.735 
MIP-1α 3.0 1.9 4.7 2.0 0.9 2.7 1.5 0.180 
PDGF 0.0 0.0 0.0 0.2 0.0 1.7 0.0 0.068 
VEGF 303.7 228.9 575.3 266.8 224.9 483.1 1.1 0.263 
 500 g bilberry baseline 500 g bilberry study end point   
IL-1ra 0.5 0.1 2.9 0.2 0.0 0.6 2.5 0.310 
IL-1β 70.6 21.8 220.5 16.1 4.1 31.9 4.4 0.025 
IL-6 119.3 73.9 280.5 48.7 25.2 80.0 2.4 0.012 
IL-12 1.5 1.2 2.3 0.7 0.6 1.9 2.1 0.310 
IP-10 389.3 135.4 990.3 176.3 113.6 659.2 2.2 0.069 
MIP-1α 3.2 1.8 7.1 1.1 0.8 2.7 2.9 0.107 
PDGF 0.8 0.0 1.7 1.5 0.1 3.5 0.5 0.237 
VEGF 479.6 250.6 680.5 180.6 87.0 238.6 2.7 0.017 
 Placebo baseline Placebo study end point   
IL-1β 70.9 21.8 196.5 30.5 23.4 88.1 2.3 0.674 
IL-6 1.5 0.3 2.2 0.6 0.3 1.6 2.5 0.889 
VEGF 330.9 299.6 592.4 305.1 188.7 723.2 1.1 0.889 
The reduction in IL-1β may be reflective of the reported antibacterial action of bilberries [15].  
Others have shown that supplementation with bilberry juice result in significant decrease in blood 
concentrations of IL-6 [16]. Furthermore, data have shown that daily bilberry consumption of 200 g 
bilberry puree and 40 g of dried bilberries over eight weeks tended to decrease blood IL-6 and IL-12 [7]. 
Elevated serum VEGF concentrations have been associated with gingival and periodontal inflammation [17]. 
VEGF may induce angiogenesis and plays a key role in periodontal disease progression and resolution [18]. 
The observed reduction in VEGF levels in GCF in the present study was in agreement with the clinically 
observed reduction in bleeding, which suggests that bilberries may have an effect on vascular inflammation.  
3. Experimental Section 
3.1. Study Individuals  
In the present study, the guidelines by the Declaration of Helsinki were followed. The Regional  
Ethics Review Board in Lund, Sweden approved the study. All participating individuals signed written 
informed consent. The study was a randomized controlled trial based on healthy individuals who were 
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≥18 years of age. Individuals were excluded if they had been treated with systemic antibiotics in the 
preceding 3 months, and/or were prescribed anti-inflammatory medications on a daily basis. Pregnant 
women were also excluded. The study individuals were allocated to either a placebo group or to groups 
that consumed either 250 or 500 g bilberries daily over seven days. The placebo group consumed potato 
starch (Potatismjöl, Lyckeby, Sweden). 
3.2. Bleeding on Probing  
Probing depth was assessed at six sites per tooth (PCR-12, Hu-Friedy, Chicago, IL, USA). Bleeding on 
probing (BOP) was assessed 30 s after probing. BOP was categorized as bleeding or no bleeding. 
3.3. Sampling from Gingival Crevicular Fluid for Cytokine Analysis 
Four sterile paper points (Periopaper, Oraflow Inc., New York, NY, USA) were inserted into selected 
pockets from the mesial surface of each first molar until resistance was met and left in situ during 30 s. 
The paper points were then placed into a labeled Eppendorf tube (1.5 mL natural flat cap microcentrifuge 
tubes, Starlab, Ahrensburg, Germany). The vials were stored in a freezer at −79 °C until processed for 
cytokine content. 
3.4. Sampling from Blood for Cytokine Analysis  
Peripheral venous blood samples were drawn into SST II vials (BD Vacutainer, Oxford, UK). The 
vials were centrifuged for 10 min at 3000× g and 4 °C. Serum was harvested and transferred into a labeled 
Eppendorf tube (1.5 mL natural flat cap microcentrifuge tubes, Starlab, Ahrensburg, Germany). The 
vials were stored in a freezer at −79° C until processed for cytokine content. 
3.5. Determination of Cytokines Using Bio-Plex Assays  
Cytokine analysis was performed according to Bio-Rad’s instructions for the xMAP technology with 
multiplex beads. Plates were measured using the Bio-Plex MagPix System and analyzed with the  
Bio-Plex Manager version 6.0 (Luminex, Austin, TX, USA). Antibody-coupled magnetic beads were 
added to each 96 well plate. The plates were washed with Bio-Plex wash buffer (2 × 100 µL). The 
content of the GCF samples were then pipetted and added to 96-well micro-plates with antibody-coupled 
beads. Samples were incubated (30 min) and washed with Bio-Plex wash buffer (3 × 100 µL) removing 
unbound protein. A 25 µL aliquot of 1 × concentration of Bio-Plex biotinylated detection antibody 
specific for a different epitope on the cytokine was added to each well, incubated (30 min), and 
subsequently washed with Bio-Plex wash buffer (3 × 100 µL). The reaction mixture was detected  
by streptavidin-phycoerythrin (streptavidin-PE). The assay was developed in a 50 µL aliquot of  
1 × concentration of streptavidin-PE (10 min), followed by a Bio-Plex wash buffer (3 × 100 µL). Beads 
were re-suspended in each well with 125 µL of Bio-Plex assay buffer and shaken on a plate shaker  
(900 rpm, 30 s). The reaction was measured using fluorescently labeled reporter molecules associated 
with each target protein. Cytokine concentrations in the samples were calculated by Bio-Plex software 
using a standard curve derived from a recombinant cytokine standard, included in the 96-well plate. The 
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following cytokines were studied: IL-1β, IL-1ra, IL-6, IL-12, interferon gamma-induced protein 10 (IP-10), 
platelet-derived growth factor (PDGF)-BB, macrophage inflammatory protein (MIP)-1α, and VEGF.  
3.6. Statistical Analysis  
Independent t-tests (equal variances not assumed), one-way ANOVA post-hoc Bonferroni, or  
non-parametric data analysis using Spearman rank correlation and Wilcoxon tests were used to assess 
levels and changes in BOP and cytokine concentrations.  
4. Conclusions  
This short-term study shows a dose dependent beneficial effect of bilberry intake on local markers of 
inflammation. Daily intake of 500 g of bilberries resulted in a clinically relevant reduction of gingival 
inflammation as well as reduction in GCF levels of pro-inflammatory levels of cytokines. The inclusion 
of a placebo group identified that participation in a study of this nature can result in important gingival 
changes. It appears that berry intake reduce gingival inflammation to the same extent as “standard of 
care”, that is routine debridement and oral hygiene instructions. 
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